Test Price
2,800 AED✅ Home Collection Available
CTNNB1 Gene Intellectual Disability (Autosomal Dominant 19) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Core Metrics
This NGS-based genetic test detects pathogenic variants in the CTNNB1 gene causing autosomal dominant intellectual disability type 19. The test offers 99.9% diagnostic sensitivity via an ISO-accredited laboratory, with premium home phlebotomy and post-test genetic counseling.
Test Overview & Methodology
This test uses Next Generation Sequencing (Illumina platform) to sequence the entire CTNNB1 gene, including copy number variant detection. All pathogenic variants are confirmed by Sanger sequencing. The test is designed to diagnose autosomal dominant intellectual disability type 19 and guide family planning decisions.
| Feature | Our Test (DHA-Compliant) | Closest Alternative |
|---|---|---|
| Precision | Full gene NGS with copy number variant detection (99.9% sensitivity) | Targeted mutation panel (limited coverage) |
| Methodology | Next Generation Sequencing (Illumina platform) + Sanger confirmation | Sanger sequencing of select exons only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Post-Test Support | Included genetic counselling teleconsultation | Report only, no interpretation |
Physician Insight & Safety Protocols
“Every CTNNB1 test must be interpreted within the full clinical picture — a negative result does not exclude other genetic aetiologies, and a positive finding opens doors to tailored early intervention. I encourage families to combine this analysis with comprehensive developmental assessments for the best outcome.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Clinical Safety Reminder
⚠ Do not discontinue any prescribed medication without consulting your doctor. Genetic test results require professional interpretation — never make treatment changes based solely on this report.
Exclusion Criteria & Emergency Red Flags
- Inability to provide a venous blood sample (e.g., severe needle phobia without alternative support).
- Patients currently on high-dose anticoagulants — consult the laboratory for alternative collection protocol.
- Emergency Red Flags: If the patient exhibits acute onset of seizures, loss of consciousness, or signs of stroke, seek immediate emergency medical care before proceeding with elective genetic testing.
Patient FAQ & Clinical Guidance
1. What conditions does the CTNNB1 gene test diagnose?
This advanced genetic test analyzes the CTNNB1 gene to diagnose autosomal dominant intellectual disability type 19 with high precision, aiding in prognosis and recurrence risk counseling.
2. How is the sample collected and what is the turnaround time?
A single blood sample is collected via VIP home phlebotomy (cold-chain) and results are delivered within 3–4 weeks using next-generation sequencing with expert clinical interpretation.
3. Is insurance accepted and what support is included?
Most UAE insurance plans cover medically necessary genetic testing — we verify your coverage directly via WhatsApp at +971545488731, and a post-test teleconsultation with our geneticist is included at no extra cost.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Compliance: All genetic data is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | CTNNB1 Gene Intellectual Disability (Autosomal Dominant 19) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next Generation Sequencing (Illumina Platform) + Sanger Confirmation |
| ICD-10-CM Code | F78 (Other intellectual disabilities) |
| LOINC Code | 21613-4 (CTNNB1 gene mutations detected in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians